Follow up

Prostate Cancer

Up to 40 percent of men diagnosed with prostate cancer will relapse¹². GE Healthcare's advanced technology can help accurately and precisely characterize abnormal tissue, during follow up assessments.

Products

LOGIQ™ E10 Ultrasound Series

Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

View product

MR_Product Listing Image_2020_320x180_3T_PETMR

SIGNA™ PETMR with QuantWorks

Our fully integrated PET/MR system combines TOF, quantitative accuracy and high sensitivity with our innovative Q.Clear reconstruction.

View product

References:

12. Prostate Cancer Recurrence [Internet]. ZERO - The End of Prostate Cancer. 2018 [cited 2 November 2018]. Available from:https://zerocancer.org/learn/survivors/recurrence/

JB04823XX